Clinical Study
Value of C-Reactive Protein as a Risk Factor for Acute Coronary Syndrome: A Comparison with Apolipoprotein Concentrations and Lipid Profile
Table 5
The risk of the acute coronary syndrome for primary and secondary variables.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*Model 0 unadjusted: = 139.2; df = 12; P < 0.001; log-likelihood = 268.0; Cox and Snell = 0.35; Nagelkerke = 0.49. Model 1 adjusted for age: = 251.8; df = 13; P = 0.001; log-likelihood = 155.4; Cox and Snell = 0.54; Nagelkerke = 0.75. Model 2 adjusted for age and sex: = 259.6; df = 14; P < 0.001; log-likelihood = 147.6; Cox and Snell = 0.55; Nagelkerke = 0.77. Model 3 adjusted for age, sex, and smoking status: = 233.4; df = 15; P < 0.001; log-likelihood = 50.9; Cox and Snell = 0.64; Nagelkerke = 0.90. apoA-I: apolipoprotein A-I; apoB: apolipoprotein B; apoB : apoA-I: apolipoprotein B to apolipoprotein A-I ratio; CI: confidence interval; HDL-C: high-density lipoprotein cholesterol; hsCRP: high-sensitivity C-reactive protein; LDL-C: low-density lipoprotein cholesterol; LDL-C : HDL-C: low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio; non-HDL-C: nonhigh-density lipoprotein cholesterol; ns: not significant; OR: odds ratio; TC: total cholesterol; TC : HDL-C: total cholesterol to high-density lipoprotein cholesterol ratio; TG: triglycerides; TG : HDL-C: triglycerides to high-density lipoprotein cholesterol ratio. |